CRMMX
Price
$24.73
Change
+$0.04 (+0.16%)
Updated
Aug 21 closing price
Net Assets
268.2M
FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
Interact to see
Advertisement

CRMMX vs FSMAX

CRMMX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
CRMMX vs. FSMAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMMX is a Hold and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. CRMMX (268M). FSMAX pays higher dividends than CRMMX: FSMAX (0.50) vs CRMMX (0.05). CRMMX was incepted earlier than FSMAX: CRMMX (26 years) vs FSMAX (15 years). CRMMX (1.22) is less costly to investors than FSMAX (0.04). CRMMX is a more actively managed with annual turnover of: 27.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than CRMMX: FSMAX (0) vs CRMMX (2500). FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. CRMMX (13.82). FSMAX return over 5 years is better than : 40.14 vs. CRMMX (-6.06).
CRMMXFSMAXCRMMX / FSMAX
Total Expense Ratio1.220.043,486%
Annual Report Gross Expense Ratio1.220.043,486%
Fund Existence26 years15 years-
Gain YTD13.33616.93779%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets268M40.1B1%
Annual Yield % from dividends0.050.5011%
Returns for 1 year13.8223.6858%
Returns for 3 years17.4472.7424%
Returns for 5 years-6.0640.14-15%
Returns for 10 years20.27134.4915%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX51.350.59
+1.16%
American Funds Intl Gr and Inc F-3
WAMVX4.940.05
+1.02%
Wasatch Micro Cap Value
RUSTX18.850.11
+0.59%
Russell Inv US Strategic Equity M
RTSGX5.740.02
+0.35%
Transamerica Small Cap Growth R6
HFDRX21.870.06
+0.28%
Hartford Schroders US MidCap Opps R3